The fund primarily invests in startups in the healthcare and biometrics fields, with notable portfolio companies including OncoResponse, On Target Laboratories, and Personal Genome Diagnostics (PGD). Startups seeking investment from the fund typically need to be between 6 and 10 years old. The fund typically participates in deals ranging from $10 million to $50 million and has a higher exit rate compared to other organizations. Its top activity was in 2018, and it is consistently involved in 2-6 investment rounds annually. Other common investors in the same rounds as the fund include VI Partners AG, High-Tech Gründerfonds, and Boehringer Ingelheim Venture Fund.